Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Elisaf

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
European Heart Journal|December 3, 1999
Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parametersE T Bairaktari, K Hatzidimou, M S Elisaf
The American Journal of Cardiology|November 13, 2001
Effects of losartan/diuretic combination treatment on serum uric acid levels in hypertensive patientsH J Milionis, S Nikas, M S Elisaf
Atherosclerosis|February 24, 2001
Lipoprotein (a) and chronic obstructive pulmonary diseaseD N Kiortsis, A Evangelou, M S Elisaf
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 24, 2007
Sibutramine-associated adverse effects: a practical guide for its safe useM Florentin, E N Liberopoulos, M S Elisaf
International Journal of Hematology|May 22, 1998
Extramedullary hemopoiesis in a patient with beta-thalassemia traitH J Milionis, R Dimitra, M S Elisaf
Lancet (London, England)|October 19, 2000
Adult cardiovascular risk factors in premature babiesD N Kiortsis, M S Elisaf, A Evangelou
European Journal of Gastroenterology & Hepatology|December 10, 1997
Post-cholecystectomy transient hundred-fold increase in CA 19-9H J Milionis, M S Elisaf, E V Tsianos
Clinical and Experimental Rheumatology|September 8, 2006
Fever with rash following zolendronic acid administrationE C Rizos, H J Milionis, M S Elisaf
Diabetes & Metabolism|April 2, 2005
The effects of orlistat on metabolic parameters and other cardiovascular risk factorsD N Kiortsis, T D Filippatos, M S Elisaf
Diabetes & Metabolism|May 17, 2001
Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitusH J Milionis, E N Liberopoulos, M S Elisaf
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
European Heart Journal|December 3, 1999
Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parametersE T Bairaktari, K Hatzidimou, M S Elisaf
The American Journal of Cardiology|November 13, 2001
Effects of losartan/diuretic combination treatment on serum uric acid levels in hypertensive patientsH J Milionis, S Nikas, M S Elisaf
Atherosclerosis|February 24, 2001
Lipoprotein (a) and chronic obstructive pulmonary diseaseD N Kiortsis, A Evangelou, M S Elisaf
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 24, 2007
Sibutramine-associated adverse effects: a practical guide for its safe useM Florentin, E N Liberopoulos, M S Elisaf
International Journal of Hematology|May 22, 1998
Extramedullary hemopoiesis in a patient with beta-thalassemia traitH J Milionis, R Dimitra, M S Elisaf
Lancet (London, England)|October 19, 2000
Adult cardiovascular risk factors in premature babiesD N Kiortsis, M S Elisaf, A Evangelou
European Journal of Gastroenterology & Hepatology|December 10, 1997
Post-cholecystectomy transient hundred-fold increase in CA 19-9H J Milionis, M S Elisaf, E V Tsianos
Clinical and Experimental Rheumatology|September 8, 2006
Fever with rash following zolendronic acid administrationE C Rizos, H J Milionis, M S Elisaf
Diabetes & Metabolism|April 2, 2005
The effects of orlistat on metabolic parameters and other cardiovascular risk factorsD N Kiortsis, T D Filippatos, M S Elisaf
Diabetes & Metabolism|May 17, 2001
Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitusH J Milionis, E N Liberopoulos, M S Elisaf
Pageof 15